Vir Biotechnology (VIR) Preferred Shares Issued (2018 - 2019)
Vir Biotechnology's (VIR) quarterly Preferred Shares Issued came in at -$7000.0 in Q2 2019, down 100.05% year-on-year from $14.5 million in Q2 2018, and down 100.0% quarter-over-quarter from $317.3 million in Q1 2019.
Vir Biotechnology (VIR) Preferred Shares Issued (2018 - 2019) Analysis & Trends
Vir Biotechnology has disclosed Preferred Shares Issued across 2 years of filings, most recently posting -$7000.0 for Q2 2019.
- Preferred Shares Issued for Q2 2019 came in at -$7000.0, down 100.05% year-over-year; the trailing twelve-month figure through Dec 2019 was $317.3 million (changed N/A YoY), and the FY2019 annual result was $317.3 million, up 2126.29% from the prior year.
- Preferred Shares Issued came in at -$7000.0 for Q2 2019 at Vir Biotechnology, down from $317.3 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $317.3 million in Q1 2019 to a low of -$7000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Vir Biotechnology | 1.27 Bn | 1.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -7,000.00 |
| Jun 30, 2019 | -7,000.00 |
| Mar 31, 2019 | 317.34 Mn |
| Mar 31, 2019 | 317.34 Mn |
| Dec 31, 2018 | 39,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Jun 30, 2018 | 14.50 Mn |
| Jun 30, 2018 | 14.50 Mn |